Purple Pumpkin Project: Did you paint yours?

This year “The Purple Pumpkin Project” was started by Ron LaMontagne and to raise Epilepsy Awareness in honor of his 7 year old son.

Check out the pictures

The goal of the project was to get people talking about how purple is the color for epilepsy. You will find some great photos of purple pumpkins on the Project’s facebook page.

From Ron and the team at the Purple Pumpkin Project: “All we are asking is to please color one of your Halloween Pumpkins Purple! Maybe have some “Seizure smart” info on hand and share your story with anyone that will listen!”

Why does it matter?

The prevalence and mortality statistics for epilepsy are comparable to those of breast cancer. More importantly, the death toll resulting from epilepsy and seizure-related causes this past year, was higher than the number of deaths resulting from AIDS-related causes at the height of the AIDS crisis.So enough pink. It’s time for purple to be the color of the day.

Let us know if you painted your pumpkin too!

Jessica K. Smith Founder and CEO; Executive Director

Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

See Full Bio